Multiple roles of the epithelium-specific ETS transcription factor, ESE-1, in development and disease

Laboratory Investigation

Volumn 92, Issue 3, 2012, Pages 320-330

  Oliver, Jordan R ^a,b   Kushwah, Rahul ^a,b   Hu, Jim ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

cancer; development; epithelial cell differentiation; ESE 1; ETS transcription factor; inflammation; regeneration

Indexed keywords

E26 TRANSFORMATION SPECIFIC TRANSCRIPTION FACTOR; EPITHELIUM SPECIFIC ETS TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; EMBRYO DEVELOPMENT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMAN; INFLAMMATION; INTESTINE DEVELOPMENT; LUNG CARCINOGENESIS; LUNG DEVELOPMENT; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; ORGANOGENESIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; REVIEW; SYNOVIUM; TISSUE REGENERATION; TISSUE SPECIFICITY; VASCULITIS;

EID: 84863287374     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.186     Document Type: Review

References (72)

1. Wasylyk B, Hahn SL, Giovane A. The Ets family of transcription factors. Eur J Biochem 1993;211:7-18. (Pubitemid 23039491)
2. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene 2003;303:11-34. (Pubitemid 36151767)
3. Wei GH, Badis G, Berger MF, et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J 2010;29:2147-2160.
4. Gutierrez-Hartmann A, Duval DL, Bradford AP. ETS transcription factors in endocrine systems. Trends Endocrinol Metab 2007;18:150-158. (Pubitemid 46629025)
5. Kageyama S, Liu H, Nagata M, et al. The role of ETS transcription factors in transcription and development of mouse preimplantation embryos. Biochem Biophys Res Commun 2006;344:675-679.
6. Jedlicka P, Gutierrez-Hartmann A. Ets transcription factors in intestinal morphogenesis, homeostasis and disease. Histol Histopathol 2008;23: 1417-1424.
7. Lincoln II DW, Bove K. The transcription factor Ets-1 in breast cancer. Front Biosci 2005;10:506-511.
8. Turner DP, Findlay VJ, Moussa O, et al. Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem 2007;102:549-559. (Pubitemid 47557410)
9. Turner DP, Watson DK. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther 2008;8:33-42.
10. Lacorazza HD, Nimer SD. The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis. Blood Cells Mol Dis 2003;31: 342-350. (Pubitemid 37433875)
11. Gupta P, Gurudutta GU, Saluja D, et al. PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis. J Cell Mol Med 2009;13:4349-4363.
12. Lelievre E, Lionneton F, Soncin F, et al. The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol 2001;33:391-407. (Pubitemid 32324006)
13. Dejana E, Taddei A, Randi AM. Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta 2007;1775:298-312. (Pubitemid 46899342)
14. Randi AM, Sperone A, Dryden NH, et al. Regulation of angiogenesis by ETS transcription factors. Biochem Soc Trans 2009;37:1248-1253.
15. Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 2006;99:1159-1166. (Pubitemid 44808652)
16. Tymms MJ, Ng AY, Thomas RS, et al. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene 1997;15:2449-2462. (Pubitemid 27503531)
17. Oettgen P, Alani RM, Barcinski MA, et al. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol 1997;17:4419-4433. (Pubitemid 27318119)
18. Feldman RJ, Sementchenko VI, Watson DK. The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. Anticancer Res 2003;23:2125-2131. (Pubitemid 36897172)
19. Prescott JD, Koto KS, Singh M, et al. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism. Mol Cell Biol 2004;24:5548-5564. (Pubitemid 38738185)
20. Manavathi B, Rayala SK, Kumar R. Phosphorylation-dependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1. J Biol Chem 2007;282: 19820-19830. (Pubitemid 47100123)
21. Zhou J, Ng AY, Tymms MJ, et al. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines. Oncogene 1998;17:2719-2732. (Pubitemid 28554231)
22. Oettgen P, Kas K, Dube A, et al. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes. J Biol Chem 1999;274: 29439-29452.
23. Kas K, Finger E, Grall F, et al. ESE-3, a novel member of an epitheliumspecific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J Biol Chem 2000;275:2986-2998. (Pubitemid 30082077)
24. Oettgen P, Finger E, Sun Z, et al. PDEF, a novel prostate epitheliumspecific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem 2000;275:1216-1225. (Pubitemid 30051174)
25. Ng AY, Waring P, Ristevski S, et al. Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. Gastroenterology 2002;122: 1455-1466. (Pubitemid 34465186)
26. Zorn AM, Wells JM. Molecular basis of vertebrate endoderm development. Int Rev Cytol 2007;259:49-111. (Pubitemid 46529407)
27. Albert M, Peters AH. Genetic and epigenetic control of early mouse development. Curr Opin Genet Dev 2009;19:113-121.
28. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
29. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448: 318-324. (Pubitemid 47080337)
30. Flentjar N, Chu PY, Ng AY, et al. TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Gastroenterology 2007;132:1410-1419. (Pubitemid 46627593)
31. Choi SG, Yi Y, Kim YS, et al. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factorbeta type II receptor. J Biol Chem 1998;273:110-117. (Pubitemid 28042183)
32. Chang J, Lee C, Hahm KB, et al. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGFbeta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells. Oncogene 2000;19: 151-154. (Pubitemid 30066361)
33. Kim JH, Wilder PJ, Hou J, et al. Activation of the murine type II transforming growth factor-beta receptor gene: up-regulation and function of the transcription factor Elf-3/Ert/Esx/Ese-1. J Biol Chem 2002;277:17520-17530. (Pubitemid 34967552)
34. Lee HJ, Chang JH, Kim YS, et al. Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines. J Exp Clin Cancer Res 2003;22: 477-480. (Pubitemid 37205407)
35. Kopp JL, Wilder PJ, Desler M, et al. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene. J Biol Chem 2004;279:19407-19420. (Pubitemid 38623374)
36. Agarkar VB, Babayeva ND, Rizzino A, et al. Preliminary crystallographic analysis of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA. Acta Crystallogr Sect F 2009;65:1261-1263.
37. Agarkar VB, Babayeva ND, Wilder PJ, et al. Crystal structure of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA. J Mol Biol 2010;397:278-289.
38. Park SH, Kim YS, Park BK, et al. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/ jen gene in human gastric cancer cell lines: implication for the loss of TGF-beta type II receptor expression. Oncogene 2001;20: 1235-1245. (Pubitemid 32226250)
39. Kwon JH, Keates S, Simeonidis S, et al. ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells. J Biol Chem 2003;278:875-884. (Pubitemid 36790761)
40. Kwon MC, Koo BK, Kim YY, et al. Essential role of CR6-interacting factor 1 (Crif1) in E74-like factor 3 (ELF3)-mediated intestinal development. J Biol Chem 2009;284:33634-33641.
41. Reddy SP, Vuong H, Adiseshaiah P. Interplay between proximal and distal promoter elements is required for squamous differentiation marker induction in the bronchial epithelium: role for ESE-1, Sp1, and AP-1 proteins. J Biol Chem 2003;278:21378-21387. (Pubitemid 36792533)
42. Oliver JR, Kushwah R, Wu J, et al. Elf3 plays a role in regulating bronchiolar epithelial repair kinetics following Clara cell-specific injury. Lab Invest 2011;91:1514-1529.
43. Atkinson JJ, Toennies HM, Holmbeck K, et al. Membrane type 1 matrix metalloproteinase is necessary for distal airway epithelial repair and keratinocyte growth factor receptor expression after acute injury. Am J Physiol Lung Cell Mol Physiol 2007;293:L600-L610. (Pubitemid 47358822)
44. Wu J, Duan R, Cao H, et al. Regulation of epithelium-specific Ets-like factors ESE-1 and ESE-3 in airway epithelial cells: potential roles in airway inflammation. Cell Res 2008;18:649-663. (Pubitemid 351793120)
45. Oettgen P, Barcinski M, Boltax J, et al. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. Genomics 1999;55:358-362.
46. Lei W, Jaramillo RJ, Harrod KS. Transactivation of lung lysozyme expression by Ets family member ESE-1. Am J Physiol Lung Cell Mol Physiol 2007;293:L1359-L1368. (Pubitemid 350159421)
47. Kushwah R, Oliver JR, Wu J, et al. Elf3 regulates allergic airway inflammation by controlling dendritic cell-driven T cell differentiation. J Immunol 2011;187:4639-4653.
48. Thomas RS, Ng AN, Zhou J, et al. The Elf group of Ets-related transcription factors. ELF3 and ELF5. Adv Exp Med Biol 2000;480: 123-128. (Pubitemid 32176102)
49. Neve R, Chang CH, Scott GK, et al. The epithelium-specific ets transcription factor ESX is associated with mammary gland development and involution. FASEB J 1998;12:1541-1550. (Pubitemid 28506723)
50. Coppe JP, Amend C, Semeiks J, et al. ERBB receptor regulation of ESX/ELF3 promotes invasion in breast epithelial cells. Open Cancer J 2010;3:89-100.
51. Walker DM, Poczobutt JM, Gonzales MS, et al. ESE-1 is required to maintain the transformed phenotype of MCF-7 and ZR-75-1 human breast cancer cells. Open Cancer J 2010;3:77-88.
52. Schedin PJ, Eckel-Mahan KL, McDaniel SM, et al. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells. Oncogene 2004;23: 1766-1779. (Pubitemid 38445168)
53. Oettgen P, Carter KC, Augustus M, et al. The novel epithelial-specific Ets transcription factor gene ESX maps to human chromosome 1q32.1. Genomics 1997;45:456-457. (Pubitemid 27467645)
54. Chang CH, Scott GK, Kuo WL, et al. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene 1997;14:1617-1622. (Pubitemid 27182846)
55. Kaplan MH, Wang XP, Xu HP, et al. Partially unspliced and fully spliced ELF3 mRNA, including a new Alu element in human breast cancer. Breast Cancer Res Treat 2004;83:171-187. (Pubitemid 38161264)
56. He J, Pan Y, Hu J, et al. Profile of Ets gene expression in human breast carcinoma. Cancer Biol Ther 2007;6:76-82. (Pubitemid 46294180)
57. Neve RM, Ylstra B, Chang CH, et al. ErbB2 activation of ESX gene expression. Oncogene 2002;21:3934-3938. (Pubitemid 34620862)
58. Eckel KL, Tentler JJ, Cappetta GJ, et al. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancerassociated gene expression. DNA Cell Biol 2003;22:79-94. (Pubitemid 36408138)
59. Andreoli JM, Jang SI, Chung E, et al. The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucleic Acids Res 1997;25: 4287-4295. (Pubitemid 27485207)
60. Cabral A, Fischer DF, Vermeij WP, et al. Distinct functional interactions of human Skn-1 isoforms with Ese-1 during keratinocyte terminal differentiation. J Biol Chem 2003;278:17792-17799. (Pubitemid 36799383)
61. Brembeck FH, Opitz OG, Libermann TA, et al. Dual function of the epithelial specific ets transcription factor, ELF3, in modulating differentiation. Oncogene 2000;19:1941-1949. (Pubitemid 30219037)
62. Sark MW, Fischer DF, de Meijer E, et al. AP-1 and ets transcription factors regulate the expression of the human SPRR1A keratinocyte terminal differentiation marker. J Biol Chem 1998;273: 24683-24692. (Pubitemid 28454968)
63. Fischer DF, Sark MW, Lehtola MM, et al. Structure and evolution of the human SPRR3 gene: implications for function and regulation. Genomics 1999;55:88-99. (Pubitemid 29058898)
64. Yoshida N, Yoshida S, Araie M, et al. Ets family transcription factor ESE-1 is expressed in corneal epithelial cells and is involved in their differentiation. Mech Dev 2000;97:27-34.
65. Jobling AI, Fang Z, Koleski D, et al. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2002;43:3530-3537. (Pubitemid 35334362)
66. Grall F, Gu X, Tan L, et al. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum 2003;48:1249-1260. (Pubitemid 36554524)
67. Brown C, Gaspar J, Pettit A, et al. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J Biol Chem 2004;279:12794-12803. (Pubitemid 38445852)
68. Peng H, Tan L, Osaki M, et al. ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol 2008;215:562-573. (Pubitemid 351468968)
69. Rudders S, Gaspar J, Madore R, et al. ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. J Biol Chem 2001;276:3302-3309.
70. Grall FT, Prall WC, Wei W, et al. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J 2005;272:1676-1687. (Pubitemid 40516218)
71. Wang H, Fang R, Cho JY, et al. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J Biol Chem 2004;279: 25241-25250. (Pubitemid 38756776)
72. Zhan Y, Yuan L, Kondo M, et al. The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling. Am J Hypertens 2010;23:1312-1317.